Form 4: Accenture CAO Plans Sale of 15 Shares Under 10b5-1 Plan
Insider Transaction Report
Accenture's Chief Accounting Officer, Melissa A. Burgum, plans to sell 15 Class A ordinary shares on February 3, 2026, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Melissa A. Burgum, Chief Accounting Officer of Accenture plc, intends to dispose of 15 Class A ordinary shares.
- The planned transaction is scheduled for February 3, 2026.
- The shares will be sold at a price of $250.43 per share.
- This disposition is being conducted pursuant to a Rule 10b5-1 trading plan, which allows insiders to sell shares at a predetermined time or price to avoid accusations of insider trading.
- Following this transaction, Melissa A. Burgum will beneficially own 8,033 Class A ordinary shares directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine disclosure of a planned insider stock sale, which is neutral in its implications for the company's overall performance or outlook.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Rule 10b5-1 trading plans are a standard mechanism for corporate insiders to sell company stock in a pre-scheduled manner, providing an affirmative defense against insider trading allegations. Such plans are common across industries for executives managing their personal portfolios.
Stakeholder Impact
- Shareholders: The sale of 15 shares represents a negligible amount relative to Accenture's total outstanding shares and market capitalization, thus having an immaterial impact on the broader shareholder base.
Next Steps
- The planned disposition of 15 Class A ordinary shares by Melissa A. Burgum on February 3, 2026.
Key Dates
| Date | Description |
|---|---|
| 02/03/2026 | Planned transaction date for the disposition of Class A ordinary shares. |
| 02/04/2026 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThe planned sale of 15 shares by a Chief Accounting Officer under a Rule 10b5-1 plan is a routine event and does not indicate any material change in the company's fundamentals or future prospects. Such a small transaction is unlikely to influence the stock price significantly or alter an investment thesis for Accenture, warranting a 'hold' recommendation.
Keywords
Accenture, ACN, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Chief Accounting Officer, Melissa A. Burgum
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.